advertisement
Journal of Ocular Pharmacology and Therapeutics 46
Showing records 1 to 25 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics120867 Neuritin 1 Drives Therapeutic Preservation of Retinal Ganglion Cells in an Human Glaucoma Model
Hameed SS
Journal of Ocular Pharmacology and Therapeutics 2024; 40: 596-607
124805 The Ocular Penetration and Intraocular Pressure Lowering Effect of Topical Acetaminophen in the New Zealand White Rabbit
Anderson SG
Journal of Ocular Pharmacology and Therapeutics 2024; 40: 513-523
122711 Preclinical and Clinical Pharmacokinetics of a New Preservative-Free Bimatoprost 0.01% Ophthalmic Gel to Treat Glaucoma and Ocular Hypertension
Erb C
Journal of Ocular Pharmacology and Therapeutics 2024; 0:
119812 Complement Factor B Inhibition or Deletion Is Not Sufficient to Prevent Neurodegeneration in a Murine Model of Glaucoma
Dolan K
Journal of Ocular Pharmacology and Therapeutics 2024; 40: 524-535
122819 Are Alpha-2 Adrenergic Agonists Being Used in Infants?
Aftab OM
Journal of Ocular Pharmacology and Therapeutics 2024; 0:
122003 Efficacy and Safety of a Preservative-Free Latanoprost Cationic Emulsion in Patients with Open-Angle Glaucoma and Concurrent Ocular Surface Disease: A Randomized Phase 2 Study
Bacharach J
Journal of Ocular Pharmacology and Therapeutics 2024; 40: 553-561
121568 Using a Novel, Subconjunctival, Sustained-Release Mitomycin C Formulation in a Rabbit Model of Filtration Surgery with Gel Stent Implantation
Lee SS
Journal of Ocular Pharmacology and Therapeutics 2024; 40: 297-308
121861 IL-22/IL-22RA1 Promotes Human Tenon's Capsule Fibroblasts Proliferation and Regulates Fibrosis Through STAT3 Signaling Pathway
Zhao Y; Zhang X
Journal of Ocular Pharmacology and Therapeutics 2024; 40: 435-444
121568 Using a Novel, Subconjunctival, Sustained-Release Mitomycin C Formulation in a Rabbit Model of Filtration Surgery with Gel Stent Implantation
Nagar S
Journal of Ocular Pharmacology and Therapeutics 2024; 40: 297-308
122003 Efficacy and Safety of a Preservative-Free Latanoprost Cationic Emulsion in Patients with Open-Angle Glaucoma and Concurrent Ocular Surface Disease: A Randomized Phase 2 Study
McLaurin EB
Journal of Ocular Pharmacology and Therapeutics 2024; 40: 553-561
120867 Neuritin 1 Drives Therapeutic Preservation of Retinal Ganglion Cells in an Human Glaucoma Model
Bodi NE
Journal of Ocular Pharmacology and Therapeutics 2024; 40: 596-607
124805 The Ocular Penetration and Intraocular Pressure Lowering Effect of Topical Acetaminophen in the New Zealand White Rabbit
Meyer D
Journal of Ocular Pharmacology and Therapeutics 2024; 40: 513-523
119812 Complement Factor B Inhibition or Deletion Is Not Sufficient to Prevent Neurodegeneration in a Murine Model of Glaucoma
Liao SM
Journal of Ocular Pharmacology and Therapeutics 2024; 40: 524-535
122711 Preclinical and Clinical Pharmacokinetics of a New Preservative-Free Bimatoprost 0.01% Ophthalmic Gel to Treat Glaucoma and Ocular Hypertension
Topouzis F
Journal of Ocular Pharmacology and Therapeutics 2024; 0:
122819 Are Alpha-2 Adrenergic Agonists Being Used in Infants?
Khan H
Journal of Ocular Pharmacology and Therapeutics 2024; 0:
124805 The Ocular Penetration and Intraocular Pressure Lowering Effect of Topical Acetaminophen in the New Zealand White Rabbit
Decloedt EH
Journal of Ocular Pharmacology and Therapeutics 2024; 40: 513-523
122003 Efficacy and Safety of a Preservative-Free Latanoprost Cationic Emulsion in Patients with Open-Angle Glaucoma and Concurrent Ocular Surface Disease: A Randomized Phase 2 Study
Silverstein S
Journal of Ocular Pharmacology and Therapeutics 2024; 40: 553-561
119812 Complement Factor B Inhibition or Deletion Is Not Sufficient to Prevent Neurodegeneration in a Murine Model of Glaucoma
Crowley M
Journal of Ocular Pharmacology and Therapeutics 2024; 40: 524-535
122711 Preclinical and Clinical Pharmacokinetics of a New Preservative-Free Bimatoprost 0.01% Ophthalmic Gel to Treat Glaucoma and Ocular Hypertension
Jayaram H
Journal of Ocular Pharmacology and Therapeutics 2024; 0:
122819 Are Alpha-2 Adrenergic Agonists Being Used in Infants?
Bargoud A
Journal of Ocular Pharmacology and Therapeutics 2024; 0:
121861 IL-22/IL-22RA1 Promotes Human Tenon's Capsule Fibroblasts Proliferation and Regulates Fibrosis Through STAT3 Signaling Pathway
Zhou X
Journal of Ocular Pharmacology and Therapeutics 2024; 40: 435-444
121568 Using a Novel, Subconjunctival, Sustained-Release Mitomycin C Formulation in a Rabbit Model of Filtration Surgery with Gel Stent Implantation
Rajagopalan L
Journal of Ocular Pharmacology and Therapeutics 2024; 40: 297-308
120867 Neuritin 1 Drives Therapeutic Preservation of Retinal Ganglion Cells in an Human Glaucoma Model
Miller RC
Journal of Ocular Pharmacology and Therapeutics 2024; 40: 596-607
121568 Using a Novel, Subconjunctival, Sustained-Release Mitomycin C Formulation in a Rabbit Model of Filtration Surgery with Gel Stent Implantation
Orilla W
Journal of Ocular Pharmacology and Therapeutics 2024; 40: 297-308
122819 Are Alpha-2 Adrenergic Agonists Being Used in Infants?
Khouri AS
Journal of Ocular Pharmacology and Therapeutics 2024; 0:
